Horellou M-H, Plu-Bureau G, Lepercq J
Service d'hématologie biologique, hôpitaux universitaires Paris Centre-Cochin, 27, rue du Faubourg-Saint-Jacques, 75679 Paris cedex14, France; Faculté de médecine Paris-Descartes, France.
Faculté de médecine Paris-Descartes, France; Service de gynécologie médicale, hôpitaux universitaires Paris Centre-Cochin, Paris, France.
Rev Med Interne. 2015 Mar;36(3):219-24. doi: 10.1016/j.revmed.2014.10.356. Epub 2014 Dec 1.
Venous thromboembolism (VTE) is a major cause of maternal morbidity and mortality during or early after pregnancy. Prior VTE or family history of VTE, clinical or biological risk factors increased the risk of pregnancy-related VTE. Defining the risk of VTE before or at the beginning of pregnancy is necessary to propose the best prevention. However, the management is not standardized between physicians, centres and countries. Current guidelines for prophylaxis and treatment of VTE are discussed in this review.
静脉血栓栓塞症(VTE)是孕期或产后早期孕产妇发病和死亡的主要原因。既往VTE病史或VTE家族史、临床或生物学风险因素会增加妊娠相关VTE的风险。在妊娠前或妊娠开始时确定VTE风险对于提出最佳预防措施很有必要。然而,医生、中心和国家之间的管理并不规范。本文综述了目前VTE预防和治疗的指南。